DaVita
DVA
#2168
Rank
C$11.84 B
Marketcap
C$165.73
Share price
-0.76%
Change (1 day)
-22.64%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): C$13.99

According to DaVita's latest financial reports the company's current EPS (TTM) is C$13.68. In 2024 the company made an earnings per share (EPS) of C$15.18 an increase over its 2023 EPS that were of C$10.47.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$13.99-7.85%
2024C$15.1844.94%
2023C$10.4727.26%
2022C$8.23-35.56%
2021C$12.7744.1%
2020C$8.8619.7%
2019C$7.40540.48%
2018C$1.16-76.07%
2017C$4.83-19.31%
2016C$5.99242.52%
2015C$1.75-62.87%
2014C$4.7113.43%
2013C$4.158.45%
2012C$3.83

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Tenet Healthcare
THC
C$20.23 47.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
C$2.61-80.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Universal Health Services
UHS
C$29.38 114.79%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$14.11 3.12%๐Ÿ‡บ๐Ÿ‡ธ USA